From: Detection and molecular characterization of urinary tract HIV-1 populations
Group | Positive samples | # of subjects with positive samples | ||||
---|---|---|---|---|---|---|
Supernatant | Pellet | Total | Supernatant | Pellet | Any | |
Overall Samples n = 97 Subjects n = 20 | 13 (13.4%) | 14 (14.4%) | 27 (13.9%) | 8 (40%) | 7 (35%) | 8 (40%) |
Treatment naïve Samples n = 84 Subjects n = 20 | 12 (14.3%) | 13 (15.5%) | 25 (15.2%) | 8 (40%) | 7 (35%) | 8 (40%) |
Virological failure (VL > 1000 RNA copies/ml) Samples n = 13 Subjects n = 7a | 0 (0%) | 1 (7.7%) | 1 (3.8%) | 0 (0%) | 1 (14.3%) | 1 (14.3%) |
Virally suppressed/low level viremia (VL < 1000 RNA copies/ml) Samples n = 21 Subjects n = 13b | 1 (4.8%) | 0 (0%) | 1 (2.4%) | 1 (7.7%) | 0 (0%) | 1 (7.7%) |